Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study

202216 citationsJournal Article

Authors

Ryo Seishima · Keio University

Koji Okabayashi · Keio University

Hiroki Ikeuchi · Hyogo University

Motoi Uchino · Hyogo University

Kitaro Futami · Fukuoka University

Tatsuki Noguchi · The University of Tokyo

Hiroki Ohge · Hiroshima University Hospital

Abstract

Biologic use was associated with a lower risk of advanced IBD-associated cancer in patients with UC but not with CD. The mechanism of cancer progression between UC and CD may be different and needs to be further investigated.

Topics & Keywords

Inflammatory Bowel Disease Microscopic Colitis Diagnosis and treatment of tuberculosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 118, Issue 7, pp. 1248-1255

DOI: 10.14309/ajg.0000000000002149

Field-Weighted Citation Impact: 2.60